134
Participants
Start Date
May 18, 2013
Primary Completion Date
July 28, 2014
Study Completion Date
July 28, 2014
GSK249320 100/mg
Clear to opalescent, colorless to pale yellow or pale brown, and is supplied as a sterile, concentrated solution (1000mg/vial). GSK249320 is for IV use only.
Placebo
Placebo is a clear, colorless solution (50mM acetate buffer, pH 5.5 containing 0.02% (w/v) polysorbate-80 and made isotonic with 111.2 mM sodium chloride). Placebo is for intravenous (IV) use only.
GSK Investigational Site, Hamburg
GSK Investigational Site, Hamburg
GSK Investigational Site, Bremen
GSK Investigational Site, Celle
GSK Investigational Site, Hanover
GSK Investigational Site, Jacksonville
GSK Investigational Site, Nashville
GSK Investigational Site, Lexington
GSK Investigational Site, Essen
GSK Investigational Site, Münster
GSK Investigational Site, Osnabrück
GSK Investigational Site, Peoria
GSK Investigational Site, Freiburg im Breisgau
GSK Investigational Site, Friedrichshafen
GSK Investigational Site, Ulm
GSK Investigational Site, Erlangen
GSK Investigational Site, Portland
GSK Investigational Site, Orange
GSK Investigational Site, Edmonton
GSK Investigational Site, Edmonton
GSK Investigational Site, London
GSK Investigational Site, Toronto
GSK Investigational Site, Greenfield Park
GSK Investigational Site, Saint-Jérôme
GSK Investigational Site, Leipzig
GSK Investigational Site, Cambridge
GSK Investigational Site, Exeter
GSK Investigational Site, Glasgow
GSK Investigational Site, Harrow
GSK Investigational Site, Liverpool
GSK Investigational Site, London
GSK Investigational Site, London
GSK Investigational Site, Newcastle upon Tyne
GSK Investigational Site, Romford
GSK Investigational Site, Salford
GSK Investigational Site, Torquay
Lead Sponsor
GlaxoSmithKline
INDUSTRY